SEC Form 4 · accession 0001019056-19-000184
Aptevo Therapeutics Inc. · APVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott C Stromatt
Officer — Chief Medical Officer and SVP
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 9:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001671584
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2019 | M | 16,269 | — | A | 221,006 | D | |
| Common Stock | Mar 1, 2019 | F | 4,823 | $1.57 | D | 216,183 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $1.52 | Feb 28, 2019 | A | 67,400 | A | — | Feb 28, 2029 | Common Stock | 67,400 | 67,400 | D |
| Restricted Stock UnitF1,F3 | — | Mar 1, 2019 | M | 16,269 | D | — | — | Common Stock | 16,269 | 0 | D |
Explanation of responses
- F1Restricted stock units (the "RSUs") convert into shares of the Issuer's common stock on a one-for-one basis.
- F2The option vests in three approximately equal annual installments beginning on February 28, 2020.
- F3The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vested in three equal annual installments beginning on the anniversary of the grant date.